Enrollment currently scheduled to begin in Q1 2026 M107 is the first potential disease-modifying drug for the treatment of gastroparesis M107’s mechanism of action has been shown to shift ...

Please provide your email address to receive an email when new articles are posted on . The evidence base was not sufficient to recommend many of the common treatments for gastroparesis. Public ...

Gastroparesis is a chronic digestive condition where the stomach muscles do not work efficiently, causing delayed emptying of food into the small intestine. This results in a range of gastroparesis ...

About 1 in 4 people have symptoms of the disorder gastroparesis, which causes the stomach to empty slowly and can cause nausea, vomiting and pain.